-
Sprache:
Deutsch
-
Medien:
Alle
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Heska Corporation setzt Telefonkonferenz zu den Finanzergebnissen und Erträgen für das vierte Quartal und volle Geschäftsjahr 2019 für den 25. Februar 2020 an
mehrHeska Corporation übernimmt scil animal care, einen europäischen Marktführer in der veterinärmedizinischen Point-of-Care-Diagnostik
mehrHeska announces new clinical chemistry analyser
mehrHeska and Novartis enter into canadian distribution pact
mehrPatent granted for Heska Corporation's equine influenza vaccine
mehrHeska Corporation to market new diagnostic product developed by Genzyme Corporation
mehrHeska Corporation reports 2000 fourth quarter and year-end results / Company delivers record annual revenue, improved margins and reduced operating expenses
mehrHeska completes US$5.7 million private placement
mehr
Heska Corporation licences genes to Torrey Mesa Research Institute to test potential allergy treatments
mehrHeska introduces new clinical chemistry analyser
mehrSechs Patente für Produkte zur Kontrolle des Flohbefalls an Heska Corporation vergeben / Das Unternehmen hält nun mehr als 100 US-Patente
mehrHeska and Novartis Enter Into European Distribution Pact
mehrHeska Enters License Agreement With Meiji
mehrDr. Edith W. Martin Elected to Heska Corporation's Board of Directors
mehrHeska Corporation Reports Continued Improvement in Third Quarter Financial Results
mehrHeska Licenses Valentis Technology for Development Of Novel Canine Cancer Treatment / Research Results Presented at Veterinary Cancer Society Meeting
mehrHeska Wins Partial Summary Judgment in Synbiotics Patent Case
mehr
Heska's ALLERCEPT(TM) Technology Proven in Clinical Allergy Studies
mehrAlliance Between Heska Corporation and Ralston Purina Results In Nutritional Product
mehrHeska Corporation Reports Continued Improvement in Second Quarter Financial Results
mehrValue of Heska's Allergy Patent Portfolio Further Validated by Circassia Deal
mehrHeska Corporation Announces Launch of New Web Site
mehrWilliam A. Aylesworth Joins Heska Corporation\047s Board of Directors
mehrHeska Corporation Obtains Expanded Credit Facility
mehrHeska Corporation Announces Sale of Center Laboratories Business to Alk-Abello / Deal Also Includes Intellectual Property License For Human Healthcare Applications
mehrHeska Corporation Announces Launch of New Feline Diagnostic Product
mehrHeska Appoints New Board Chairman
mehrHeska Corporation Reports Record Revenues in First Quarter Results / Company Delivers Strong Revenue Growth, Higher Margins and Improved Operating Results
mehrHeska Corporation Announces Sale of Dental Product to Pharmacia & Upjohn
mehr
12Nächste